Zeleciment rostudirsen (z-rostudirsen)

Name: Zeleciment rostudirsen (z-rostudirsen) in Duchenne muscular dystrophy: Effect of Zeleciment rostudirsen on quality measures
Published: 2026-09-14T15:39:06-04:00

Duchenne muscular dystrophy

Also known as DYNE-251

Manufacturer: Dyne Therapeutics
Regulatory submission: BLA submitted May 2026
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Effect of Zeleciment rostudirsen on quality measures

1 evidence topic · 1 source

Z-rostudirsen-specific effect on quality measures

No evidence found.

Evaluation of care-consideration implementation

“We identify key elements of care and present suggestions for their use in evaluation and research.” (opens the source at this quote in a new tab)